A Mentor-Based Approach to Long-Term Weight Loss
1 other identifier
interventional
174
1 country
1
Brief Summary
The purpose of this study to examine the effect of having a weight loss mentor on long-term weight loss in overweight adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Sep 1999
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2002
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedSeptember 15, 2005
September 1, 2005
September 13, 2005
September 13, 2005
Conditions
Outcome Measures
Primary Outcomes (1)
weight loss
Secondary Outcomes (3)
fitness
dietary intake
mediators
Interventions
Eligibility Criteria
You may qualify if:
- Female
- years of age
- BMI = 25-35 kg/m2
- Ability to provide informed consent.
- Ability to provide consent from their personal physician to participate in this study.
You may not qualify if:
- Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.)
- Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.
- Currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy will be based on self-report and will be included on the detailed medical history that is completed by subjects.)
- Non-medicated resting systolic blood pressure \>160 mmHg or non-medicated resting diastolic blood pressure \>100 mmHg, or taking medication that would affect blood pressure.
- Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).
- Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.
- History of myocardial infarction or valvular disease.
- History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John M Jakicic, Ph.D.
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 15, 2005
Study Start
September 1, 1999
Study Completion
July 1, 2002
Last Updated
September 15, 2005
Record last verified: 2005-09